GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) will report its fourth quarter and full year 2022 financial results on February 28, 2023, after U.S. markets close. A conference call is scheduled for 2:00 p.m. PT (5:00 p.m. ET) to discuss these results and provide insights into the company’s future outlook. Investors can pre-register for the call and access a live webcast through GoodRx's investor relations website. Since 2011, GoodRx has saved consumers over $45 billion, offering affordable medication prices and telehealth services.

Positive

• GoodRx saved consumers over $45 billion since 2011.
• Leading digital healthcare platform with high download rates.

Negative

• None.

SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company’s business outlook.

To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.

Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.

About GoodRx

GoodRx is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans. We offer consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. Since 2011, we have helped consumers save over $45 billion and are one of the most downloaded medical apps over the past decade.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005919/en/

Investor Contact

GoodRx

Whitney Notaro

ir@goodrx.com

Press Contact

GoodRx

Lauren Casparis

lcasparis@goodrx.com

Source: GoodRx Holdings Inc.

FAQ

When will GoodRx release its Q4 2022 financial results?

GoodRx will release its fourth quarter and full year 2022 financial results on February 28, 2023, after U.S. markets close.

What time is the GoodRx Q4 results conference call?

The conference call will begin at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on February 28, 2023.

How can I access GoodRx's Q4 2022 financial results call?

Investors can pre-register for the call via a provided link or access the live webcast on GoodRx's investor relations website.

What is GoodRx's stock symbol?

GoodRx's stock symbol is GDRX.

How much have consumers saved through GoodRx since its inception?

Consumers have saved over $45 billion through GoodRx since 2011.